Among the large number of metabolic enzymes described as crucial regulators of cancer cell survival and resistance, the glycosyltransferase EXT2 is of interest due to its putative tumor suppressor function whose mutation causes the type II form of multiple exostoses, a disease characterized by the formation of osteochondromas [23]. This evidence concerns the gene EXT2 and cancer.